EWING, N.J., Aug. 9, 2016 /PRNewswire/ -- Essential Pharmaceuticals, LLC will play an important role at the upcoming 8th Annual Bioprocessing Summit in Boston, Massachusetts, August 15-19. The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today's bioprocess challenges. Essential Pharmaceuticals will present data on the product Cell-Ess® during the plenary session and poster session. Cell-Ess is the world's first, universal titer boost and enhancer that works across a wide range of media systems. Essential Pharmaceuticals will be exhibiting as well (booth #303), where high traffic and extensive technical discussion is expected.
Cell-Ess used as a feed consistently improves protein titer by 20-50%% compared to control in various cell lines and media schemes. The increase is observed in glass shake flasks and single-use Wave BioreactorsTM that were scalable to 10,000 liters. In a new video, Essential Pharmaceuticals CEO Allan Weber and CSO Dr. Adam Elhofy discuss why Cell-Ess was invented, what makes it different from traditional media supplements and feeds, and the impact on bioproduction productivity, efficiency and cost management.
"Cell-Ess is different because it can be used with any media platform," says Dr. Elhofy. "Most supplements and feeds must be used with their coordinating base media. Cell-Ess is unique because it can be utilized across all commercially-available media platforms as well as unique platforms that companies have developed for their own systems."
"Cell-Ess utilizes a patent-pending lipid delivery mechanism that allows free fatty acids and cholesterol to be taken up by the cell," says Allan. "By providing lipids to the cells, Cell-Ess helps stabilize cell membranes and improve protein synthesis, allowing each cell to increase monoclonal antibody production. Unlike other products, the novel delivery method utilized by Cell-Ess limits free fatty acids and cholesterol from oxidation, degrading, and sticking to bioproduction vessel walls."
During the Summit, Dr. Elhofy will be presenting his talk "Increasing Protein Production with Novel Cell-Ess Supplement" during Stream 1 on Thursday, August 18th at 9:00 am in Harbor Room 1. He will be presenting his poster #B14 during Session 1B Bioproduction: Scale, Bioreactors & Disposables on Wednesday, August 17th and Thursday, August 18th.
About Essential Pharmaceuticals
Essential Pharmaceuticals provides transplant surgeons, medical researchers, and manufacturers new tools to bring performance, convenience, and control to enhance the advancement of basic research and drug discovery. Established in 2006, Essential Pharmaceuticals supports the preservation and growth of human systems through expanding its product development to further medical treatments for mankind.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/essential-pharmaceuticals-llc-and-dr-adam-elhofy-chosen-to-present-about-how-to-increase-bioproduction-productivity-during-the-upstream-processing-plenary-session-at-the-2016-bioprocessing-summit-300310704.html
SOURCE Essential Pharmaceuticals, LLC